Literature DB >> 27363879

Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea.

Nicole M Fett1, David Fiorentino2, Victoria P Werth3.   

Abstract

Patients with skin-predominant lupus erythematosus, dermatomyositis, and morphea should be evaluated, treated, and followed by dermatologists who can take primary responsibility for their care. Many academic centers have specialized centers with dermatologists who care for these patients. Patients with skin-predominant lupus erythematosus should be followed regularly with laboratory tests to detect significant systemic disease. Antibody tests can help determine the risks for individual patients. Patients with morphea rarely progress to systemic disease, but therapies can be helpful in treating and preventing progression of disease. Published by Elsevier Inc.

Entities:  

Keywords:  Dermatomyositis; Educational gaps; Lupus; Morphea; Practice

Mesh:

Year:  2016        PMID: 27363879      PMCID: PMC5514844          DOI: 10.1016/j.det.2016.02.006

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  40 in total

1.  High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea.

Authors:  Virginie Lutz; Camille Francès; Didier Bessis; Anne Cosnes; Nicolas Kluger; Julien Godet; Erik Sauleau; Dan Lipsker
Journal:  Arch Dermatol       Date:  2011-10-17

2.  Expanding retrieval practice promotes short-term retention, but equally spaced retrieval enhances long-term retention.

Authors:  Jeffrey D Karpicke; Henry L Roediger
Journal:  J Exp Psychol Learn Mem Cogn       Date:  2007-07       Impact factor: 3.051

3.  Reflection in diagnostic reasoning: what really matters?

Authors:  Sílvia Mamede; Henk G Schmidt
Journal:  Acad Med       Date:  2014-07       Impact factor: 6.893

4.  Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.

Authors:  Lauren Okon; Misha Rosenbach; Michael Krathen; Mathew Rose; Kathleen Propert; Joyce Okawa; Victoria Werth
Journal:  J Am Acad Dermatol       Date:  2014-03       Impact factor: 11.527

5.  Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.

Authors:  David J Browning
Journal:  Am J Ophthalmol       Date:  2012-12-04       Impact factor: 5.258

Review 6.  Update on pathogenesis and treatment of CLE.

Authors:  Emily D Privette; Victoria P Werth
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

7.  Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis.

Authors:  R Q Klein; C A Bangert; M Costner; M K Connolly; A Tanikawa; J Okawa; M Rose; S S Fakharzadeh; D Fiorentino; L A Lee; R D Sontheimer; L Taylor; A B Troxel; V P Werth
Journal:  Br J Dermatol       Date:  2008-07-04       Impact factor: 9.302

8.  A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings.

Authors:  Yvonne E Chiu; Sheetal Vora; Eun-Kyung M Kwon; Mohit Maheshwari
Journal:  Pediatr Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.588

Review 9.  Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis.

Authors:  Xin Lu; Hanbo Yang; Xiaoming Shu; Fang Chen; Yinli Zhang; Sigong Zhang; Qinglin Peng; Xiaolan Tian; Guochun Wang
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 10.  The diagnostic utility of autoantibodies in adult and juvenile myositis.

Authors:  Sarah L Tansley; Zoe E Betteridge; Neil J McHugh
Journal:  Curr Opin Rheumatol       Date:  2013-11       Impact factor: 5.006

View more
  2 in total

1.  Alopecias in lupus erythematosus.

Authors:  Josef Symon Salgado Concha; Victoria P Werth
Journal:  Lupus Sci Med       Date:  2018-10-25

2.  Dermatomyositis sine myositis - Case presentation.

Authors:  Evripidis Kaltsonoudis; Eleftherios Pelechas; Alexandros A Drosos
Journal:  Mediterr J Rheumatol       Date:  2017-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.